Page 2 - Raju Mohan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Raju mohan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Raju Mohan Today - Breaking & Trending Today

Ventyx Biosciences (NASDAQ:VTYX) Releases Earnings Results, Beats Estimates By $0.08 EPS

Ventyx Biosciences (NASDAQ:VTYX – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($0.79) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.87) by $0.08, Briefing.com reports. During the same period in the prior year, the company earned ($0.62) earnings per share. Ventyx Biosciences Stock Performance Shares of […] ....

John Nuss , Ventyx Biosciences , Raju Mohan , Stifel Nicolaus , Wells Fargo Company , Ventyx Biosciences Company Profile , Citigroup Inc , Morgan Stanley , Royal Bank , Jpmorgan Chase Co , Renaissance Technologies , Ventyx Biosciences Inc , Get Free Report , Amalgamated Bank , Ventyx Biosciences Daily ,

Ventyx Biosciences (NASDAQ:VTYX) Issues Quarterly Earnings Results

Ventyx Biosciences (NASDAQ:VTYX – Get Free Report) posted its quarterly earnings data on Tuesday. The company reported ($0.79) EPS for the quarter, beating analysts’ consensus estimates of ($0.87) by $0.08, Briefing.com reports. During the same period in the previous year, the firm earned ($0.62) earnings per share. Ventyx Biosciences Price Performance Shares of NASDAQ VTYX […] ....

Ventyx Biosciences , Raju Mohan , John Nuss , Ventyx Biosciences Inc , Vanguard Group Inc , Blackrock Inc , Pricet Rowe Associates Inc , Ventyx Biosciences Company Profile , Goldman Sachs Group Inc , Wells Fargo Company , Securities Exchange Commission , Morgan Stanley , Get Free Report , Exchange Commission , Goldman Sachs Group , Sachs Group , Wells Fargo , Ventyx Biosciences Daily ,

Connor Clark & Lunn Investment Management Ltd. Acquires 37,240 Shares of Ventyx Biosciences, Inc. (NASDAQ:VTYX)

Connor Clark & Lunn Investment Management Ltd. increased its holdings in Ventyx Biosciences, Inc. (NASDAQ:VTYX – Free Report) by 139.5% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 63,944 shares of the company’s stock after purchasing an additional 37,240 shares during the period. Connor Clark […] ....

Raju Mohan , John Nuss , Ventyx Biosciences , Stifel Nicolaus , Connor Clark Lunn Investment Management Ltd , Life Insurance Co , Ventyx Biosciences Inc , Wells Fargo Company , Ameritas Investment Partners Inc , Group Plc , Ventyx Biosciences Company Profile , China Universal Asset Management Co , Morgan Stanley , Connor Clark , Lunn Investment Management , Free Report , Universal Asset Management , General Group Plc , Ameritas Investment Partners , Investment Partners , Get Free Report , Ventyx Biosciences Daily , Nasdaq Vtyx , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Ventyx Biosciences (NASDAQ:VTYX) Announces Earnings Results

Ventyx Biosciences (NASDAQ:VTYX – Get Free Report) posted its earnings results on Tuesday. The company reported ($0.79) EPS for the quarter, beating the consensus estimate of ($0.87) by $0.08, Briefing.com reports. During the same period last year, the firm earned ($0.62) earnings per share. Ventyx Biosciences Stock Up 27.6 % NASDAQ:VTYX traded up $1.67 during […] ....

Stifel Nicolaus , Ventyx Biosciences , John Nuss , Raju Mohan , Wells Fargo Company , Ventyx Biosciences Inc , Pricet Rowe Associates Inc , Vanguard Group Inc , Bridgeway Capital Management , Blackrock Inc , Ventyx Biosciences Company Profile , Get Free Report , Ventyx Biosciences Daily ,

Ventyx Biosciences (NASDAQ:VTYX) Releases Quarterly Earnings Results, Beats Estimates By $0.08 EPS

Ventyx Biosciences (NASDAQ:VTYX – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($0.79) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.87) by $0.08, Briefing.com reports. During the same quarter in the prior year, the business posted ($0.62) earnings per share. Ventyx Biosciences Stock Up 27.6 […] ....

Stifel Nicolaus , Ventyx Biosciences , John Nuss , Raju Mohan , Ventyx Biosciences Company Profile , Sphera Funds Management , Securities Exchange Commission , Ventyx Biosciences Inc , Capital Partners , Vanguard Group Inc , Voloridge Investment Management , Get Free Report , Exchange Commission , Funds Management , Investment Management , Occudo Quantitative Strategies , Ventyx Biosciences Daily , Nasdaq Vtyx ,